Layn to debut highly bioavailable form of quercetin at SupplySide West

Called bio+Quercitrin, the ingredient is said to be up to six times more bioavailable than standard quercetin.

Layn Natural Ingredients (Irvine, CA) will showcase its latest launch, a highly bioavailable form of quercetin, at the SupplySide West trade show, taking place October 31 to November 4, 2022, in Las Vegas (Booth #5065). The ingredient is called bio+Quercitrin, and according to the company it is up to six times more bioavailable than standard quercetin.

“Layn’s bio+Quercitrin has a ribose molecule attached to it, making it more absorbable and permeable in the small intestine, providing up to six times better bioavailability than regular quercetin,” the company says in a press release. “Because bio+Quercitrin is absorbed more efficiently than standard quercetin, the benefits of quercetin are realized within the body more rapidly and fully.”

The ingredient’s enhanced bioavailability enables dietary supplement brands to reduce the amount of ingredient in each dosage, resulting in lower raw material costs, Layn points out. This also lets brands achieve an efficacious dose in a smaller pill size and possibly lessen gastrointestinal issues some users experience with traditional quercetin supplements, the company says. The ingredient can be used in a range of nutraceutical delivery forms, including powders, capsules, tablets, softgels, gummies, bars, and liquid shots.

Quercetin’s benefits include scavenging free radicals and helping to manage oxidative stress and has roles in immune health, healthy aging, heart health, gut health, joint health, cellular support, and more.